PI
PALI icon

Putnam Investments’s Palisade Bio PALI Stock Holding History

Putnam Investments’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-3
Closed -$1.07M – 1325
2016
Q2 		$1.07M Sell
3
-1
-25% -$530K ﹤0.01% 1090
2016
Q1 		$3.46M Hold
4
– – 0.01% 789
2015
Q4 		$4.75M Hold
4
– – 0.01% 677
2015
Q3 		$5.54M Hold
4
– – 0.01% 634
2015
Q2 		$8.79M Hold
4
– – 0.02% 526
2015
Q1 		$8.62M Hold
4
– – 0.02% 563
2014
Q4 		$12.1M Hold
4
– – 0.02% 451
2014
Q3 		$13.8M Buy
4
+1
+33% +$4.03M 0.03% 397
2014
Q2 		$14.9M Hold
3
– – 0.03% 384
2014
Q1 		$12.5M Buy
+3
New +$12.4M 0.03% 420

Other funds holding PALI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
JPCCM
J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Putnam Investments's PALI Position: Q3 2016 in Review

Putnam Investments sold out of Palisade Bio (PALI) in Q3 2016, closing a stake of 3 shares — an estimated $1.07M sold.

Putnam Investments first reported a position in PALI in Q1 2014 and held it in 10 quarters. The position peaked at $14.9M in Q2 2014. 5 funds tracked by Wall St. Rank hold PALI as of Q3 2016.

  • Putnam Investments reported no remaining Palisade Bio position as of Q3 2016 after selling out during the quarter.
  • Putnam Investments sold 3 Palisade Bio shares in Q3 2016, an estimated $1.07M.
  • Putnam Investments first reported a position in Palisade Bio in Q1 2014 and held it in 10 quarters.
  • Putnam Investments's Palisade Bio position peaked at $14.9M in Q2 2014.
  • 5 funds tracked by Wall St. Rank held Palisade Bio as of Q3 2016.

Based on Putnam Investments's 13F filing for Q3 2016, filed 14 Nov 2016.